Loading the records…
Loading the records…
The LIVE Beneficiaries Act (HR1403) is an early-stage bill requiring states to quarterly verify Medicaid enrollee deaths through SSA's Death Master File. With zero authorized funding, one referral to committee, and only 3 cosponsors, near-term market impact is negligible. Data verification IT services could see minor demand, but no company is named and no spending authorized.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
No actionable market signal. The LIVE Beneficiaries Act is a procedural bill with no funding mechanism, no named beneficiaries, and low legislative priority. IT services firms with Medicaid exposure (IBM, ACN, DXC) are in broad market downturns that have nothing to do with this bill. Retail investors should not trade based on this event.
HR1403, the LIVE Beneficiaries Act, was introduced on February 18, 2025 by Rep. Bilirakis (R-FL) and referred to the House Energy and Commerce Committee. The bill requires state Medicaid programs to check the Social Security Administration's Death Master File on a quarterly basis to identify and disenroll deceased enrollees, effective January 1, 2027. The bill has only 3 cosponsors and no companion bill has advanced in the Senate, indicating low legislative momentum.
The money trail is the critical factor here: the bill authorizes ZERO dollars for implementation. States would bear the full cost of upgrading their Medicaid eligibility systems to support quarterly Death Master File checks. This is an unfunded mandate on states, which reduces the likelihood of passage and means any IT contract opportunities would be at state expense, not through new federal spending. The bill's single referral to committee and limited action history suggest it is not a priority.
Structural winners would be IT services firms with state government Medicaid system expertise, including IBM, Accenture, and DXC. However, the lack of authorized funding makes this a speculative, low-confidence call. No company is named in the bill, and the legislative path is long and uncertain. These tickers are included at low confidence due to the bill's early stage and absence of spending authorization.
Real market data shows all three tickers in downtrends over the past month, unrelated to this bill. IBM ($226.72) is down 6.46% in 30 days, Accenture ($175.66) is down 11.42%, and DXC ($11.47) is down 8.75%. The bill's negligible impact does not alter these structural trends.
Timeline: The bill has been in committee since February 2025 with no further action. For it to become law, it must pass the House, pass the Senate, and be signed by the President. Even if passed, implementation is not until January 2027. Without authorized funding or significant bipartisan momentum, the probability of enactment in the 119th Congress is low.
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
Matched on shared policy language across AI analyses, with ticker & timing weight
DELL FEDERAL SYSTEMS L.P: $1.1B Department of Veterans Affairs Contract
MERCK SHARP & DOHME LLC: $2.0B Department of Health and Human Services Contract Vehicle
Raytheon Co.: $2.6B Department of Defense Contract
UTAH DEPARTMENT OF HEALTH AND HUMAN SERVICES: $3.4B Department of Health and Human Services Grant
TRIWEST HEALTHCARE ALLIANCE CORP: $1.2B Department of Veterans Affairs Contract
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
MULTIPLE RECIPIENTS: $1.7B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $5.6B Department of Health and Human Services Federal Award
Executive orders & memoranda affecting the same sectors or companies
The President invokes Section 232 of the Trade Expansion Act to declare that imports of robotics, industrial machinery, and their components threaten national security, and directs the Secretary of Commerce and USTR to negotiate agreements with trading partners to adjust these imports, potentially leading to tariffs or quotas within 180 days.
This proclamation initiates negotiations to adjust imports of wind turbines and their components under Section 232, citing national security concerns including cybersecurity vulnerabilities, radar interference, and grid reliability. It does not immediately impose tariffs but sets the stage for potential trade restrictions, and notes that certain wind turbine components made of aluminum, steel, or copper are already subject to existing tariffs.
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →